Comparing the risks of hospitalized heart failure associated with glinide, sulfonylurea, and acarbose use in type 2 diabetes: A nationwide study
Journal
International journal of cardiology
Journal Volume
228
Pages
1007
Date Issued
2017-02-01
Author(s)
Lee, Yen-Chieh
Dong, Yaa-Hui
Wu, Li-Chiu
Hwang, Jing-Shiang
Abstract
Increasing evidence suggests that certain newer anti-diabetic drugs are associated with an increased risk of hospitalized heart failure (HHF). However, the potential risks associated with the use of sulfonylurea and glinide have not been carefully evaluated.
Subjects
Acarbose; Glinides; Heart failure; Sulfonylurea
SDGs
Publisher
ELSEVIER IRELAND LTD
Type
journal article